Jisheng Li

1.3k total citations
57 papers, 636 citations indexed

About

Jisheng Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jisheng Li has authored 57 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Jisheng Li's work include Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Jisheng Li is often cited by papers focused on Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Jisheng Li collaborates with scholars based in China, United Kingdom and Hong Kong. Jisheng Li's co-authors include Xiuwen Wang, Ling Peng, Qiji Liu, Hui Guo, Justin Stebbing, Georgios Giamas, Lili Li, Jie Wu, Qian Tao and Bin Xu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Jisheng Li

53 papers receiving 630 citations

Peers

Countries citing papers authored by Jisheng Li

Since Specialization

Citations

This map shows the geographic impact of Jisheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jisheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jisheng Li more than expected).

Fields of papers citing papers by Jisheng Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jisheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jisheng Li. The network helps show where Jisheng Li may publish in the future.

Co-authorship network of co-authors of Jisheng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jisheng Li. A scholar is included among the top collaborators of Jisheng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jisheng Li. Jisheng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of immunotherapy or antiangiogenic agent-based treatment strategies versus chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a network meta-analysis 2025 ·Frontiers in Pharmacology ·Chengjun Wang, (unknown), Wen Zhao, Rongyu Zhang, (unknown), Jisheng Li	1
2	The efficacy and safety of a novel PD-1/CTLA-4 bispecific antibody cadonilimab (AK104) in advanced non-small cell lung cancer: A multicenter retrospective observational study in China. 2024 ·Journal of Clinical Oncology ·Jisheng Li, Shuwen Yu, (unknown), Hongxin Li, (unknown), Hongchang Shen, Meiying Li, Chengjun Wang, Jian Wang, (unknown), (unknown), (unknown), Jun Wang, Xiuwen Wang, Lian Liu	1
3	The patient outcomes with EGFR-mutated advanced non-small-cell lung cancer receiving aumolertinib as first-line treatment. 2024 ·Journal of Clinical Oncology ·Jisheng Li, Zhao Wen, Hongxin Li, (unknown), Chengjun Wang, Rongyu Zhang, (unknown), Jian Wang, (unknown)	0
4	Efficacy and Safety of Maintenance Therapy Using Cetuximab in Patients with Metastatic Colorectal Cancer: Retrospective Study 2024 ·Cancer Management and Research ·(unknown), (unknown), (unknown), Jiaxin Li, Jisheng Li, Fangli Cao, (unknown)	1
5	Social networks, environmental literacy, and farmers' clean low-carbon farming behaviors: Evidence from villages in China 2024 ·Ecological Economics ·(unknown), Jisheng Li, (unknown)	4
6	An infrared spectroscopic and Ab initio investigation of aqueous boric acid solutions: Evidence for the structure and transformation of the polyboric acid molecules 2024 ·Journal of Molecular Liquids ·Fayan Zhu, (unknown), (unknown), (unknown), Yanan Wu, Yunhong Zhang, Jianming Pan, Yongquan Zhou, Jisheng Li	2
7	The efficacy and safety of a novel PD‐1/CTLA‐4 bispecific antibody cadonilimab (AK104) in advanced non‐small cell lung cancer: A multicenter retrospective observational study 2024 ·Thoracic Cancer ·Hongxin Li, (unknown), Chengming Li, Hongchang Shen, Meiying Li, Chengjun Wang, (unknown), (unknown), Jun Wang, (unknown), Lian Liu, Shuwen Yu, Jisheng Li	4
8	Hydrolysis mechanism of the cyclohexaborate anion: Unraveling the intricacies 2024 ·Journal of Computational Chemistry ·(unknown), Yunxia Wang, Lulu Song, (unknown), (unknown), Jisheng Li, Yongquan Zhou, (unknown), Fayan Zhu	1
9	Dorsomorphin attenuates ABCG2-mediated multidrug resistance in colorectal cancer 2024 ·Frontiers in Pharmacology ·Xiaopeng Li, (unknown), (unknown), Ke He, (unknown), Jisheng Li, (unknown), Yubin Su, Zhongmin Yuan, (unknown)	4
10	Effects of recharge process on groundwater nitrate concentration in an oasis of Tengger Desert hinterland, China 2023 ·Environmental Science and Pollution Research ·(unknown), Heping Shu, Jisheng Li, Jianhua He	1
11	Real-World Efficacy and Safety of Thoracic Radiotherapy after First-Line Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer 2023 ·Journal of Clinical Medicine ·(unknown), Jingru Liu, Min Wu, (unknown), Yuhan Lu, (unknown), (unknown), Jisheng Li, Xue Meng	16
12	A Lung Cancer Patient Harboring a Rare Oncogenic EGFR Exon 20 V786M Mutation Responded to a Third-Generation Tyrosine Kinase Inhibitor: Case Report and Review of the Literature 2022 ·Frontiers in Oncology ·Qi Zhu, (unknown), Wenfei Li, (unknown), Jisheng Li, Justin Stebbing, Xiaodong Liang, Ling Peng	2
13	Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer 2021 ·Cancer Management and Research ·Ying Sun, Beibei Chen, Jisheng Li, Ling Peng, Shuguang Li, (unknown), Li Li	7
14	Increased microbial loading in aerosols produced by non-contact air-puff tonometer and relative suggestions for the prevention of coronavirus disease 2019 (COVID-19) 2020 ·PLoS ONE ·Hui Guo, Wei Li, (unknown), Xiaoyan Li, Zhi Li, Hongxia Zhou, (unknown), Li Li, Jisheng Li	7
15	The CUL4B/AKT/β-Catenin Axis Restricts the Accumulation of Myeloid-Derived Suppressor Cells to Prohibit the Establishment of a Tumor-Permissive Microenvironment 2015 ·Cancer Research ·Yanyan Qian, Jupeng Yuan, Huili Hu, Qifeng Yang, Jisheng Li, Shuqian Zhang, Baichun Jiang, Changshun Shao, Yaoqin Gong	47
16	Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer 2015 ·BMC Cancer ·Jintong Du, Bei Li, (unknown), Yanguo Liu, Yang Wang, Jisheng Li, Wen Zhou, Xiuwen Wang	42
17	Effect of Wind-solar Complementary Increasing Oxygen System in Aquaculture 2013 ·Advance Journal of Food Science and Technology ·(unknown), (unknown), Jisheng Li, Yong Hou, (unknown)	2
18	Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells 2013 ·Tumor Biology ·Meiying Li, (unknown), Hui Guo, Limei Sun, Aijun Wang, Qiji Liu, Xiuwen Wang, Jisheng Li	50
19	A functional polymorphism in the SPINK5 gene is associated with asthma in a Chinese Han Population 2009 ·BMC Medical Genetics ·Qiji Liu, Yu Xia, Wenjing Zhang, Jisheng Li, Pin Wang, Huaichen Li, Chunhua Wei, Yaoqin Gong	22
20	Time dependent changes of nNOS positive neurons in mouse cerebral cortex after acute lithium administration 2005 ·Fang Yang, Jisheng Li, (unknown), Heng Zhang, (unknown), Jun Chen	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact